U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD
Non-Invasive, Self-Neuromodulation, Adjunct to Standard of Care Therapy Using Amygdala Derived EEG-fMRI Pattern Biomarkers to Help Patients with PTSD…
Understand your body better with the new ECG App from Garmin
FDA-cleared and clinically-validated app lets Venu 2 Plus customers record an ECG and check for signs of atrial fibrillation…
AliveCor Lists its Industry-leading KardiaMobile 6L in Epic’s App Orchard Marketplace
KardiaMobile 6L personal ECG now integrated into Epic EHR AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology,…
Aidoc Releases the First ‘OS’ Unifying AI Across Enterprise Imaging to Address Technical Barriers of Using AI
Health networks can now continuously expand their AI stack without overhauling their IT infrastructure with each new tool Aidoc,…
Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
TRUDHESA Is the First and Only Therapeutic to Use POD technology to Deliver Dihydroergotamine Mesylate (DHE) to the Vascular-Rich…
Q&A: FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer’s Drug Approval
An interview between Healthline and former FDA panel member. Dr. Aaron S. Kesselheim, MPH, began advising the Food and…
BioIntelliSense Announces FDA Clearance of the BioSticker™, the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring
An effortless patient experience combined with actionable clinical intelligence to bring medical-grade care to the home BioIntelliSense, Inc., a…